Early warning system for Alzheimer's disease

Apr 21, 2011
These are University of Strathclyde research team members Professor David Birch, Mariana Amaro and Dr. Olaf Rolinski. Credit: University of Strathclyde

Scientists at the University of Strathclyde in Glasgow are developing a technique based on a new discovery which could pave the way towards detecting Alzheimer's disease in its earliest stages - and could help to develop urgently-needed treatments.

The technique uses the ratio of detected fluorescence signals to indicate that clusters of peptide associated with the disease are beginning to gather and to have an impact on the brain.

Current techniques are not able to see the peptide joining together until more advanced stages but a research paper from Strathclyde describes an approach which could not only give indications of the condition far sooner than is currently possible but could also screen patients without the need for needles or wires.

, the most common form of , currently affects around 450,000 people in the UK alone and currently has no cure.

Dr Olaf Rolinski, of the University of Strathclyde's Department of Physics, led the research. He said: "Alzheimer's Disease has a devastating impact on people around the world and their families but one of the reasons it is still incurable is that little is known about how and why the peptide that contributes to the disease aggregates in its initial stages.

"When irradiated with light, the intrinsic fluorescence given off by the peptide is like a communication from a spy. We took samples of the peptide and discovered that, where they were in the type of aggregation linked to Alzheimer's, they produced fluorescence light signals which could be picked up with our technique much earlier than in more conventional experiments, such as those that use the addition of a dye .

"This approach could help us understand better the role of these in the onset of Alzheimer's and discover ways in which the disease could be stopped in its tracks early on. We now want to take the research further so that it can be used in the development of drugs to treat Alzheimer's."

Explore further: Haunting tales in ship-wrecked silver

More information: The research paper, by Dr Rolinski and colleagues Professor David Birch and research student Mariana Amaro, has been published in Physical Chemistry Chemical Physics.

Provided by University of Strathclyde

4.5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

Yeast model shows promise as Alzheimer's test

Nov 18, 2006

A century ago this month, German psychiatrist Alois Alzheimer formally described characteristics of the neurodegenerative disease which ultimately came to bear his name. While international efforts to learn about Alzheimer's ...

Epilepsy drug shows potential for Alzheimer's treatment

Dec 08, 2008

A drug commonly used to treat epilepsy could help clear the plaques in the brain associated with Alzheimer's disease, according to researchers at the University of Leeds. The plaques are known to lead to the progressive ...

Recommended for you

The origins of handedness in life

4 hours ago

Handedness is a complicated business. To simply say life is left-handed doesn't even begin to capture the blooming hierarchy of binary refinements it continues to evolve. Over the years there have been numerous ...

Have our bodies held the key to new antibiotics all along?

7 hours ago

As the threat of antibiotic resistance grows, scientists are turning to the human body and the trillion or so bacteria that have colonized us—collectively called our microbiota—for new clues to fighting microbial infections. ...

Characterizing an important reactive intermediate

12 hours ago

An international group of researchers led by Dr. Warren E. Piers (University of Calgary) and Dr. Heikki M. Tuononen (University of Jyväskylä) has been able to isolate and characterize an important chemical ...

Surfaces that communicate in bio-chemical Braille

12 hours ago

A Braille-like method that enables medical implants to communicate with a patient's cells could help reduce biomedical and prosthetic device failure rates, according to University of Sydney researchers.

User comments : 0